Online inquiry

IVTScrip™ mRNA-Human ARMCX3, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK23260MR)

This product GTTS-WK23260MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ARMCX3 protein. This product can be used in Migration phase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_016607.4
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 51566
UniProt ID Q9UH62
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ARMCX3, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK23260MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK22543MR IVTScrip™ mRNA-Human APPL1, (Cap 0, 2-Thio-UTP, 120 nt-poly(A)) mRNA APPL1
GTTS-WK21149MR IVTScrip™ mRNA-Human AMER3, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA AMER3
GTTS-WK21768MR IVTScrip™ mRNA-Human ARPC3, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) mRNA ARPC3
GTTS-WK25678MR IVTScrip™ mRNA-Human ARRDC1-AS1, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ARRDC1-AS1
GTTS-WK12535MR IVTScrip™ mRNA-Human ADGRD2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ADGRD2
GTTS-WK25663MR IVTScrip™ mRNA-Human ARNTL, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ARNTL
GTTS-WK9711MR IVTScrip™ mRNA-Human ACAP1, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ACAP1
GTTS-WK28211MR IVTScrip™ mRNA-Human APLNR, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA APLNR
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →